Publicação:
Prospective evaluation of early virological response associated with peginterferon alfa-2a (40KD) (Pegasys (R)) and ribavirin from a phase IV, randomized study examining the effects of treatment duration-in hepatitis C patients infected with genotype 1.

Página do item simplificado
dc.contributor.authorBrandao, C. E.
dc.contributor.authorPerez-Gomez, R.
dc.contributor.authorPessoa, M. G.
dc.contributor.authorOlivera-Martinez, M. A.
dc.contributor.authorCaramori, Carlos Antonio [UNESP]
dc.contributor.authorBazan-Perez, C. V.
dc.contributor.authorPatelli, M.
dc.contributor.authorTorres-Ibarra, R.
dc.contributor.authorBarone, A.
dc.contributor.authorDehesa-Violante, M.
dc.contributor.authorCarrilho, F.
dc.contributor.authorVivar, R.
dc.contributor.authorTatsch, F.
dc.contributor.institutionGraffee & Guinle Hosp
dc.contributor.institutionCivil Hosp Guadalajara
dc.contributor.institutionEmilio Ribas Infect Dis Hosp
dc.contributor.institutionNatl Inst Med Sci & Nutr
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionTijuana Gen Hosp
dc.contributor.institutionPUCAMP
dc.contributor.institutionInfect Dis Hosp
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.contributor.institutionNatl Med Ctr
dc.contributor.institutionRoche Mexico
dc.contributor.institutionF Hoffmann La Roche & Co Ltd
dc.date.accessioned2014-05-20T15:28:44Z
dc.date.available2014-05-20T15:28:44Z
dc.date.issued2002-10-01
dc.description.affiliationGraffee & Guinle Hosp, Gaffree, Brazil
dc.description.affiliationCivil Hosp Guadalajara, Guadalajara, Jalisco, Mexico
dc.description.affiliationEmilio Ribas Infect Dis Hosp, São Paulo, Brazil
dc.description.affiliationNatl Inst Med Sci & Nutr, Mexico City, DF, Mexico
dc.description.affiliationUniv Estadual Paulista Julio Mesquita Filho, Botucatu, SP, Brazil
dc.description.affiliationTijuana Gen Hosp, Tijuana, Mexico
dc.description.affiliationPUCAMP, São Paulo, Brazil
dc.description.affiliationInfect Dis Hosp, Guadalajara, Jalisco, Mexico
dc.description.affiliationUniv São Paulo, BR-05508 São Paulo, Brazil
dc.description.affiliationNatl Med Ctr, Mexico City, DF, Mexico
dc.description.affiliationRoche Mexico, Mexico City, DF, Mexico
dc.description.affiliationF Hoffmann La Roche & Co Ltd, São Paulo, Brazil
dc.description.affiliationUnespUniv Estadual Paulista Julio Mesquita Filho, Botucatu, SP, Brazil
dc.format.extent364A-364A
dc.identifier.citationHepatology. Philadelphia: W B Saunders Co, v. 36, n. 4, p. 364A-364A, 2002.
dc.identifier.issn0270-9139
dc.identifier.lattes5518720125698768
dc.identifier.urihttp://hdl.handle.net/11449/38496
dc.identifier.wosWOS:000178301700787
dc.language.isoeng
dc.publisherW B Saunders Co
dc.relation.ispartofHepatology
dc.relation.ispartofjcr14.079
dc.relation.ispartofsjr5,541
dc.rights.accessRightsAcesso restrito
dc.sourceWeb of Science
dc.titleProspective evaluation of early virological response associated with peginterferon alfa-2a (40KD) (Pegasys (R)) and ribavirin from a phase IV, randomized study examining the effects of treatment duration-in hepatitis C patients infected with genotype 1.en
dc.typeResumo
dcterms.licensehttp://olabout.wiley.com/WileyCDA/Section/id-406071.html
dcterms.rightsHolderW B Saunders Co
dspace.entity.typePublication
unesp.author.lattes5518720125698768[5]
unesp.author.orcid0000-0002-0390-1061[5]
unesp.campusUniversidade Estadual Paulista (Unesp), Faculdade de Medicina, Botucatupt
unesp.departmentClínica Médica - FMBpt

Arquivos

Licença do Pacote

Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição:

Coleções

Botucatu - FMB - Faculdade de Medicina